We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$239M
AUM Growth
+$15.5M
Cap. Flow
+$3.07M
Cap. Flow %
1.28%
Top 10 Hldgs %
51.84%
Holding
156
New
12
Increased
23
Reduced
28
Closed
7

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.86M
2
PJP icon
Invesco Pharmaceuticals ETF
PJP
+$1.03M
3
AAPL icon
Apple
AAPL
+$922K
4
LHX icon
L3Harris
LHX
+$904K
5
HD icon
Home Depot
HD
+$872K

Sector Composition

Rank Sector Weight
1 Healthcare 27.82%
2 Energy 9.19%
3 Financials 5.08%
4 Communication Services 4.83%
5 Technology 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
126
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$251K 0.1%
3,149
+10
+0.3% +$795
MHD icon
127
BlackRock MuniHoldings Fund
MHD
$606M
$249K 0.1%
15,000
APA icon
128
APA Corp
APA
$13.2B
$246K 0.1%
4,783
RYAAY icon
129
Ryanair
RYAAY
$31.3B
$242K 0.1%
7,313
VDE icon
130
Vanguard Energy ETF
VDE
$9.84B
$241K 0.1%
2,500
VZ icon
131
Verizon
VZ
$196B
$234K 0.1%
4,800
PKW icon
132
Invesco BuyBack Achievers ETF
PKW
$1.76B
$233K 0.1%
4,500
DLB icon
133
Dolby
DLB
$5.79B
$229K 0.1%
+4,369
New +$216K
RSP icon
134
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$227K 0.09%
2,500
BMY icon
135
Bristol-Myers Squibb
BMY
$132B
$226K 0.09%
4,152
-2,821
-40% -$155K
MRK icon
136
Merck
MRK
$318B
$222K 0.09%
3,673
AMLP icon
137
Alerian MLP ETF
AMLP
$13.1B
$217K 0.09%
+3,420
New +$220K
MDT icon
138
Medtronic
MDT
$112B
$208K 0.09%
+2,585
New +$202K
IWM icon
139
iShares Russell 2000 ETF
IWM
$81.9B
$206K 0.09%
+1,496
New +$204K
IBB icon
140
iShares Biotechnology ETF
IBB
$9.71B
$205K 0.09%
2,100
-1,950
-48% -$187K
ABBV icon
141
AbbVie
ABBV
$435B
$203K 0.08%
+3,120
New +$196K
PGX icon
142
Invesco Preferred ETF
PGX
$3.78B
$203K 0.08%
13,730
CDK
143
DELISTED
CDK Global, Inc.
CDK
$202K 0.08%
+3,113
New +$199K
BCRX icon
144
BioCryst Pharmaceuticals
BCRX
$2.4B
$168K 0.07%
20,000
IMGN
145
DELISTED
Immunogen Inc
IMGN
$133K 0.06%
34,315
TERP
146
DELISTED
TerraForm Power, Inc
TERP
$123K 0.05%
+10,000
New +$121K
IRD
147
Opus Genetics
IRD
$302M
$76K 0.03%
313
DARE icon
148
Dare Bioscience
DARE
$21M
$16K 0.01%
167
HD icon
149
Home Depot
HD
$355B
-6,500
Closed -$872K
HON icon
150
Honeywell
HON
$78B
-2,214
Closed -$232K

Similar funds

Northeast Financial Consultants's Q1 2017 Portfolio in Review

As of Q1 2017, Northeast Financial Consultants held 156 positions worth $239M, up 6.9% from $224M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Northeast Financial Consultants's Q1 2017 filing shows 12 new, 23 increased, 28 reduced and 7 closed positions. Its largest new stake was First Trust Dow Jones Internet Index Fund ETF: 17,254 shares worth $1.52M. The largest sale was Pfizer, an estimated $1.86M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.

  • Northeast Financial Consultants's largest Q1 2017 buy was First Trust Dow Jones Internet Index Fund ETF: 17,254 shares worth $1.52M.
  • Northeast Financial Consultants added most to Vanguard Financials ETF in Q1 2017, an estimated $1.56M increase.
  • Northeast Financial Consultants's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.86M.
  • Northeast Financial Consultants fully exited Home Depot in Q1 2017, selling an estimated $872K.
  • Northeast Financial Consultants's ten largest holdings make up 52% of its $239M portfolio in Q1 2017.
  • Northeast Financial Consultants opened 12 new positions and closed 7 in Q1 2017.
  • Northeast Financial Consultants's portfolio value rose 6.9% quarter-over-quarter to $239M.

Based on Northeast Financial Consultants's 13F filing for Q1 2017, filed 28 Apr 2017.